Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Folic acid supplementation for women with epilepsy who might become pregnant

Abstract

Low folate levels are associated with an increased risk of spontaneous abortion and congenital malformations. Up to half of all pregnancies are unplanned, so official guidelines in a number of countries, including the US, recommend folic acid supplementation for all women who might become pregnant, before they actually start planning to have children. Children born to women who are taking antiepileptic medications, many of which antagonize folate action, are at an increased risk of birth defects. This article highlights a study by Pittschieler et al. that has suggested that supplementation with folic acid might be particularly important in women with epilepsy who are taking antiepileptic medications—especially valproate. However, the sample size in the study was too small to determine the optimum dose or to detect whether folic acid protects against birth defects. Nonetheless, it is clear that all women of reproductive age, especially those taking certain antiepileptic medications, should take folic acid supplements.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Meador KJ et al. (2007) Cognitive/behavioral teratogenetic effects of antiepileptic drugs. Epilepsy Behav 11: 292–302

    Article  Google Scholar 

  2. Marson AG et al. (2007) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369: 1016–1026

    Article  CAS  Google Scholar 

  3. Pennell PB (2004) Pregnancy in women who have epilepsy. Neurol Clin 22: 799–820

    Article  Google Scholar 

  4. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338: 131–137

  5. [No authors listed] (1998) Practice parameter: management issues for women with epilepsy (summary statement): report of the Quality Standards Subcommittee of the American Academy of Neurology. Epilepsia 39: 1226–1231

  6. Hernández-Díaz S et al. (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 343: 1608–1614

    Article  Google Scholar 

  7. Pittschieler S et al. (2008) Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy. J Neurol [10.1007/s00415-008-0029-1]

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andre H Lagrange.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lagrange, A. Folic acid supplementation for women with epilepsy who might become pregnant. Nat Rev Neurol 5, 16–17 (2009). https://doi.org/10.1038/ncpneuro0970

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0970

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing